Stordahl Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Buy
+938
New +$321K 0.06% 55
2020
Q4
Sell
-843
Closed -$214K 48
2020
Q3
$214K Buy
+843
New +$209K 0.11% 40
2020
Q1
Sell
-843
Closed -$203K 39
2019
Q4
$203K Buy
+843
New +$186K 0.08% 45
2019
Q1
Sell
-1,403
Closed -$273K 50
2018
Q4
$273K Hold
1,403
0.13% 38
2018
Q3
$278K Hold
1,403
0.12% 35
2018
Q2
$259K Hold
1,403
0.12% 36
2018
Q1
$239K Sell
1,403
-167
-11% -$30.7K 0.11% 40
2017
Q4
$273K Buy
+1,570
New +$278K 0.13% 36

Other funds holding AMGN

Stordahl Capital Management's AMGN Position: Q2 2026 in Review

Stordahl Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 938 shares worth $340K. The stake represents 0.06% of the portfolio and ranks #55 among its holdings. This is a return to the name: Stordahl Capital Management previously reported a position in AMGN as recently as Q3 2020.

Stordahl Capital Management first reported a position in AMGN in Q4 2017 and has held it in 8 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stordahl Capital Management held 938 shares of Amgen worth $340K as of Q2 2026.
  • Amgen was a new Stordahl Capital Management position in Q2 2026.
  • Amgen made up 0.06% of Stordahl Capital Management's portfolio in Q2 2026, its #55 holding.
  • Stordahl Capital Management first reported a position in Amgen in Q4 2017 and has held it in 8 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stordahl Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.